Skip to main navigation Skip to search Skip to main content

Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer 8)

Teresa Morán, Eudald Felip, Joaquim Bosch-Barrera, Itziar De Aguirre, Jose Luis Ramirez, Carles Mesia, Enric Carcereny, Diana Roa, Elia Sais, Yolanda García, Remei Blanco, Silvia Sanchez, Claudia Rosa Villacorta, Cristina Queralt, Jose María Velarde, Rafael Rosell

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This article has been corrected: The correct affiliation information is given below: 1 Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. Original article: Oncotarget. 2018; 9:27074-27086. https://doi.org/10.18632/oncotarget.25478.
Original languageEnglish
Pages (from-to)2576
Number of pages1
JournalOncotarget
Volume10
Issue number26
DOIs
Publication statusPublished - 1 Apr 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer 8)'. Together they form a unique fingerprint.

Cite this